Orencia
Disease-Modifying Antirheumatic Agent
Abatacept / Maltose, Preservative Free
250 mg / 15 mL Intravenous Injection
Single Use Vial 15 mL
Bristol-Myers Squibb 00003218710

Orencia
Disease-Modifying Antirheumatic Agent
Abatacept / Maltose, Preservative Free
250 mg / 15 mL Intravenous Injection
Single Use Vial 15 mL
Bristol-Myers Squibb 00003218710

1- REGULATIONS ON PURCHASE OF THESE PRODUCTS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE. 2-THESE ITEMS WOULD BE USED ONLY BY QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , HEALTH CARE PROVIDERS , .... ) WITH VALID PROFESSIONAL LICENSE. 3- ANY INQUIRY REGARDING THESE ITEMS WOULD BE PROCESSED AFTER VERIFICATION OF VALID LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )

Manufacturer # 00003218710 Brand Orencia® Manufacturer Bristol-Myers Squibb Application Disease-Modifying Antirheumatic Agent Container Type Single Use Vial Dosage Form Injection Generic Drug Code 26306 Generic Drug Name Abatacept / Maltose, Preservative Free NDC Number 00003-2187-10 Storage Requirements Requires Refrigeration Strength 250 mg / 15 mL Type Intravenous UNSPSC Code 51201806 Volume 15 mL Features

ORENCIA® (abatacept) is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA